Related Experiment Videos
USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst
Andre M Oliveira1, Bae-Li Hsi, Stanislawa Weremowicz
1Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. amoliveira@parthers.org
Cancer Research
|March 18, 2004
Summary
Aneurysmal bone cysts (ABCs) may have a neoplastic origin. A specific chromosomal translocation creates a fusion gene, leading to deregulated USP6 transcription and potentially driving ABC development.
Area of Science:
- Oncology
- Genetics
- Bone Biology
Background:
- Aneurysmal bone cyst (ABC) is a locally aggressive bone lesion primarily affecting young individuals.
- Historically considered non-neoplastic, recent studies suggest a neoplastic basis due to observed chromosomal abnormalities.
- Specific translocations, like t(16;17)(q22;p13), have been identified in some ABC cases.
Purpose of the Study:
- To investigate the genetic mechanisms underlying Aneurysmal Bone Cyst (ABC) formation.
- To identify specific gene fusions resulting from chromosomal translocations in ABC.
- To elucidate the oncogenic pathway involving CDH11 and USP6 in ABC.
Main Methods:
- Cytogenetic analysis of ABC samples.
- Detection of fusion gene transcripts using molecular techniques.
- Analysis of gene expression patterns, specifically CDH11 and USP6.
Main Results:
- A recurring translocation t(16;17)(q22;p13) in ABC creates a CDH11-USP6 fusion gene.
- CDH11-USP6 fusion transcripts were detected exclusively in ABCs with the t(16;17) translocation.
- Alternative CDH11 or USP6 rearrangements were found in other ABCs, indicating diverse genetic mechanisms.
- CDH11, highly expressed in bone, drives USP6 transcription via its promoter.
Conclusions:
- The study implicates a novel oncogenic mechanism in ABC pathogenesis.
- Deregulated USP6 transcription, driven by the CDH11 promoter, contributes to ABC development.
- Genetic alterations involving CDH11 and USP6 are key drivers in a subset of Aneurysmal Bone Cysts.